PMC:7441777 / 41885-42740
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T57 | 6-11 | Body_part | denotes | colon | http://purl.org/sig/ont/fma/fma14543 |
T58 | 29-33 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T59 | 70-80 | Body_part | denotes | intestinal | http://purl.org/sig/ont/fma/fma7199 |
T60 | 334-343 | Body_part | denotes | intestine | http://purl.org/sig/ont/fma/fma7199 |
T61 | 457-469 | Body_part | denotes | glycoprotein | http://purl.org/sig/ont/fma/fma62925 |
T62 | 473-485 | Body_part | denotes | glycoprotein | http://purl.org/sig/ont/fma/fma62925 |
T63 | 516-523 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T64 | 566-578 | Body_part | denotes | glycoprotein | http://purl.org/sig/ont/fma/fma62925 |
T65 | 616-628 | Body_part | denotes | glycoprotein | http://purl.org/sig/ont/fma/fma62925 |
T66 | 675-687 | Body_part | denotes | glycoprotein | http://purl.org/sig/ont/fma/fma62925 |
T67 | 794-806 | Body_part | denotes | glycoprotein | http://purl.org/sig/ont/fma/fma62925 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T7 | 6-11 | Body_part | denotes | colon | http://purl.obolibrary.org/obo/UBERON_0001155 |
T8 | 334-343 | Body_part | denotes | intestine | http://purl.obolibrary.org/obo/UBERON_0000160 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T72 | 6-26 | Disease | denotes | colon adenocarcinoma | http://purl.obolibrary.org/obo/MONDO_0002271 |
T73 | 12-26 | Disease | denotes | adenocarcinoma | http://purl.obolibrary.org/obo/MONDO_0004970 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T223 | 0-5 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | Human |
T224 | 6-11 | http://purl.obolibrary.org/obo/UBERON_0001155 | denotes | colon |
T225 | 29-38 | http://purl.obolibrary.org/obo/CLO_0000031 | denotes | cell line |
T226 | 40-45 | http://purl.obolibrary.org/obo/CLO_0002172 | denotes | Caco2 |
T227 | 40-45 | http://purl.obolibrary.org/obo/CLO_0051943 | denotes | Caco2 |
T228 | 40-45 | http://purl.obolibrary.org/obo/CLO_0051958 | denotes | Caco2 |
T229 | 40-45 | http://purl.obolibrary.org/obo/CLO_0051960 | denotes | Caco2 |
T230 | 64-69 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T231 | 70-80 | http://purl.obolibrary.org/obo/UBERON_0000160 | denotes | intestinal |
T232 | 70-80 | http://www.ebi.ac.uk/efo/EFO_0000834 | denotes | intestinal |
T233 | 156-157 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T234 | 252-257 | http://purl.obolibrary.org/obo/CLO_0002172 | denotes | Caco2 |
T235 | 252-257 | http://purl.obolibrary.org/obo/CLO_0051943 | denotes | Caco2 |
T236 | 252-257 | http://purl.obolibrary.org/obo/CLO_0051958 | denotes | Caco2 |
T237 | 252-257 | http://purl.obolibrary.org/obo/CLO_0051960 | denotes | Caco2 |
T238 | 328-333 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T239 | 334-343 | http://purl.obolibrary.org/obo/UBERON_0000160 | denotes | intestine |
T240 | 334-343 | http://www.ebi.ac.uk/efo/EFO_0000834 | denotes | intestine |
T241 | 507-515 | http://purl.obolibrary.org/obo/UBERON_0000158 | denotes | membrane |
T242 | 562-565 | http://purl.obolibrary.org/obo/CLO_0001547 | denotes | a P |
T243 | 612-615 | http://purl.obolibrary.org/obo/CLO_0001547 | denotes | a P |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T573 | 158-162 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T574 | 188-192 | Chemical | denotes | EGCG | http://purl.obolibrary.org/obo/CHEBI_4806 |
T575 | 206-209 | Chemical | denotes | TF3 | http://purl.obolibrary.org/obo/CHEBI_136608 |
T576 | 215-225 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
T577 | 371-375 | Chemical | denotes | EGCG | http://purl.obolibrary.org/obo/CHEBI_4806 |
T578 | 389-392 | Chemical | denotes | TF3 | http://purl.obolibrary.org/obo/CHEBI_136608 |
T579 | 398-408 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
T580 | 457-469 | Chemical | denotes | glycoprotein | http://purl.obolibrary.org/obo/CHEBI_17089 |
T581 | 473-485 | Chemical | denotes | glycoprotein | http://purl.obolibrary.org/obo/CHEBI_17089 |
T582 | 516-523 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T583 | 534-544 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
T584 | 566-578 | Chemical | denotes | glycoprotein | http://purl.obolibrary.org/obo/CHEBI_17089 |
T585 | 581-590 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T586 | 596-600 | Chemical | denotes | EGCG | http://purl.obolibrary.org/obo/CHEBI_4806 |
T587 | 605-608 | Chemical | denotes | TF3 | http://purl.obolibrary.org/obo/CHEBI_136608 |
T588 | 616-628 | Chemical | denotes | glycoprotein | http://purl.obolibrary.org/obo/CHEBI_17089 |
T589 | 629-631 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T590 | 632-641 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T591 | 675-687 | Chemical | denotes | glycoprotein | http://purl.obolibrary.org/obo/CHEBI_17089 |
T592 | 694-696 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T593 | 697-706 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T594 | 794-806 | Chemical | denotes | glycoprotein | http://purl.obolibrary.org/obo/CHEBI_17089 |
T595 | 818-820 | Chemical | denotes | S3 | http://purl.obolibrary.org/obo/CHEBI_29388 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T17 | 70-91 | http://purl.obolibrary.org/obo/GO_0050892 | denotes | intestinal absorption |
T18 | 471-485 | http://purl.obolibrary.org/obo/GO_0008559 | denotes | P-glycoprotein |
T19 | 500-506 | http://purl.obolibrary.org/obo/GO_0140352 | denotes | efflux |
T20 | 500-506 | http://purl.obolibrary.org/obo/GO_0140115 | denotes | efflux |
T21 | 564-578 | http://purl.obolibrary.org/obo/GO_0008559 | denotes | P-glycoprotein |
T22 | 614-628 | http://purl.obolibrary.org/obo/GO_0008559 | denotes | P-glycoprotein |
T23 | 673-687 | http://purl.obolibrary.org/obo/GO_0008559 | denotes | P-glycoprotein |
T24 | 792-806 | http://purl.obolibrary.org/obo/GO_0008559 | denotes | P-glycoprotein |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1203 | 200-204 | Gene | denotes | TF2b | Gene:2959 |
1204 | 383-387 | Gene | denotes | TF2b | Gene:2959 |
1205 | 471-485 | Gene | denotes | P-glycoprotein | Gene:5243 |
1206 | 564-578 | Gene | denotes | P-glycoprotein | Gene:5243 |
1207 | 660-664 | Gene | denotes | TF2b | Gene:2959 |
1208 | 792-806 | Gene | denotes | P-glycoprotein | Gene:5243 |
1209 | 507-515 | Gene | denotes | membrane | Gene:43740571 |
1210 | 0-5 | Species | denotes | Human | Tax:9606 |
1211 | 64-69 | Species | denotes | human | Tax:9606 |
1212 | 328-333 | Species | denotes | human | Tax:9606 |
1213 | 673-687 | Gene | denotes | P-glycoprotein | Gene:5243 |
1214 | 614-628 | Gene | denotes | P-glycoprotein | Gene:5243 |
1215 | 188-192 | Chemical | denotes | EGCG | MESH:C045651 |
1216 | 215-225 | Chemical | denotes | remdesivir | MESH:C000606551 |
1217 | 371-375 | Chemical | denotes | EGCG | MESH:C045651 |
1218 | 398-408 | Chemical | denotes | remdesivir | MESH:C000606551 |
1219 | 534-544 | Chemical | denotes | remdesivir | MESH:C000606551 |
1220 | 596-600 | Chemical | denotes | EGCG | MESH:C045651 |
1221 | 6-26 | Disease | denotes | colon adenocarcinoma | MESH:D003110 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T423 | 0-163 | Sentence | denotes | Human colon adenocarcinoma-2 cell line (Caco2) permeability and human intestinal absorption (HIA) are key parameters to decide the total bioavailability of a drug. |
T424 | 164-370 | Sentence | denotes | All the five compounds (EGCG, TF2a, TF2b, TF3, and remdesivir) showed comparatively low Caco2 permeability potential (<8 × 10−6 cm/s) and could be absorbed via the human intestine (Larregieu & Benet, 2013). |
T425 | 371-524 | Sentence | denotes | EGCG, TF2a, TF2b, TF3, and remdesivir were predicted to be substrates of permeability glycoprotein (P-glycoprotein), which is an efflux membrane protein. |
T426 | 525-707 | Sentence | denotes | However, remdesivir was predicted as a P-glycoprotein I inhibitor, and EGCG and TF3 as a P-glycoprotein II inhibitor, whereas TF2a and TF2b as both P-glycoprotein I and II inhibitor. |
T427 | 708-855 | Sentence | denotes | Hence, above mentioned five compounds could regulate the physiological functions of P-glycoprotein (see Table S3 in the Supplementary Information). |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32720577-23344793-56195132 | 364-368 | 23344793 | denotes | 2013 |